Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 161 L-VIR: Management of Low-level Persistent Viremia
NCT02247687Phase 3Terminated
- Sponsor
- ANRS
- Start
- Dec 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir, raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Dec 2014; status: terminated.
02
Drugs
darunavirraltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02247687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247687.